Title: The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.
Journal: Future oncology (London, England) 20150101
Title: Ixazomib for the treatment of multiple myeloma.
Journal: Expert opinion on investigational drugs 20150101
Title: Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity.
Journal: Molecular & cellular proteomics : MCP 20121201
Title: Next-generation proteasome blockers promise safer cancer therapy.
Journal: Nature medicine 20120106
Title: Drugs: More shots on target.
Journal: Nature 20111214
Title: Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20111201
Title: In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110815
Title: Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
Journal: Journal of medicinal chemistry 20110714
Title: Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer.
Journal: Cancer research 20100301
